Bruno Emond

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Topics

Chronic Lymphocytic Leukemia

Genome Wide Identification

Small Cell Lung Cancer

Top Venues

Current oncology (Toronto, Ont.)

Journal of medical economics

PharmacoEconomics - open

This page only lists publications with an associated author ORCID identifier.

Publications

Christine M Bestvina, Dexter Waters, Laura Morrison, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Andy He, Julie Vanderpoel
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer. Journal of medical economics 27 (1) (2024)
Christine M Bestvina, Dexter Waters, Laura Morrison, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Andy He, Julie Vanderpoel
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer. Journal of medical economics (2024)
Christine M Bestvina, Dexter Waters, Laura Morrison, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Andy He, Julie Vanderpoel
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer. Journal of medical economics 27 (1) (2024)
Brandon S Sheffield, Kiefer Eaton, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Laura Morrison, Andrea L Stevens, Emmanuel M Ewara, Parneet Cheema
Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ryan Jacobs, Xiaoxiao Lu, Bruno Emond, Laura Morrison, Frederic Kinkead, Patrick Lefebvre, Marie-Hélène Lafeuille, Wasiulla Khan, Linda H Wu, Zaina P Qureshi, Moshe Yair Levy
Time to next treatment in patients with chronic lymphocytic leukemia initiating first-line ibrutinib or acalabrutinib. Future oncology (London, England) (2023)
Peter F Rebeiro, Bruno Emond, Carmine Rossi, Brahim K Bookhart, Aditi Shah, Gabrielle Caron-Lapointe, Marie-Hélène Lafeuille, Prina Donga
Incidence of cardiometabolic outcomes among people living with HIV-1 initiated on integrase strand transfer inhibitor versus non-integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United States. Journal of the International AIDS Society 26 (6) (2023)
Brandon S Sheffield, Kiefer Eaton, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Laura Morrison, Andrea L Stevens, Emmanuel M Ewara, Parneet Cheema
Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices. Current oncology (Toronto, Ont.) 30 (2) (2023)
Brandon S Sheffield, Kiefer Eaton, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Laura Morrison, Andrea L Stevens, Emmanuel M Ewara, Parneet Cheema
Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices. Current oncology (Toronto, Ont.) 30 (2) (2023)
Julie Vanderpoel, Bruno Emond, Isabelle Ghelerter, Katherine Milbers, Marie-Hélène Lafeuille, Patrick Lefebvre, Lorie A Ellis
Healthcare Resource Utilization and Costs in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer Receiving First-Line Treatment in the United States: An Insurance Claims-Based Descriptive Analysis. PharmacoEconomics - open (2023)
Prina Donga, Bruno Emond, Carmine Rossi, Brahim K Bookhart, Johnnie Lee, Gabrielle Caron-Lapointe, Fangzhou Wei, Marie-Hélène Lafeuille
Weight and BMI Changes Following Initiation of Emtricitabine/Tenofovir Alafenamide Co-Formulated with Darunavir or Co-Administered with Dolutegravir in Overweight or Obese, ART-Naïve People Living with HIV-1. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Xiaoxiao Lu, Bruno Emond, Laura Morrison, Frederic Kinkead, Patrick Lefebvre, Marie-Hélène Lafeuille, Wasiulla Khan, Linda H Wu, Zaina P Qureshi, Ryan Jacobs
Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia. Patient preference and adherence 17 (2023)
Brandon S Sheffield, Kiefer Eaton, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Laura Morrison, Andrea L Stevens, Emmanuel M Ewara, Parneet Cheema
Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices. Current oncology (Toronto, Ont.) 30 (2) (2023)
Brandon S Sheffield, Kiefer Eaton, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Laura Morrison, Andrea L Stevens, Emmanuel M Ewara, Parneet Cheema
Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices. Current oncology (Toronto, Ont.) 30 (2) (2023)
Brandon S Sheffield, Kiefer Eaton, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Laura Morrison, Andrea L Stevens, Emmanuel M Ewara, Parneet Cheema
Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices. Current oncology (Toronto, Ont.) 30 (2) (2023)
Iris Lin, Richard Melsheimer, Rachel H Bhak, Patrick Lefebvre, Maral DerSarkissian, Bruno Emond, Angela Lax, Catherine Nguyen, Melody Wu, Yinong Young-Xu
Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab. Current medical research and opinion 38 (4) (2022)
Grace A McComsey, Bruno Emond, Aditi Shah, Brahim K Bookhart, Carmine Rossi, Katherine Milbers, Marie-Hélène Lafeuille, Prina Donga
Association Between Weight Gain and the Incidence of Cardiometabolic Conditions Among People Living with HIV-1 at High Risk of Weight Gain Initiated on Antiretroviral Therapy. Infectious diseases and therapy 11 (5) (2022)
Julie Vanderpoel, Andrea L Stevens, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Laura Morrison
Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancer. Journal of medical economics 25 (1) (2022)
Menno Vergeer, Wendela L de Ranitz-Greven, Maureen P Neary, Raluca Ionescu-Ittu, Bruno Emond, Mei Sheng Duh, Floor Jansen, Bernard A Zonnenberg
Epilepsy, impaired functioning, and quality of life in patients with tuberous sclerosis complex. Epilepsia open 4 (4) (2019)